The Changing Paradigm for the Pharmaceutical Sector
High medicine prices impose a burden on national healthcare systems, for which pharmaceuticals account for a significant share of spending, especially for countries in the early stages of maturity in the pharma sector. Craig Wylie, Vikas Kharbanda, Dhiraj Joshi, Dr. Regien Sumo, Mario Elhoyek and Dobromira Boyadjieva at Arthur D. Little discuss competition in the pharma sector and present an integrated framework for authorities to strengthen pharma competition.